18alpha-glycyrrhetinic acid

18alpha-glycyrrhetinic acid is a lipid of Prenol Lipids (PR) class. 18alpha-glycyrrhetinic acid is associated with abnormalities such as Wiskott-Aldrich Syndrome. The involved functions are known as inhibitors, salivary gland development and branching morphogenesis.

Cross Reference

Introduction

To understand associated biological information of 18alpha-glycyrrhetinic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 18alpha-glycyrrhetinic acid?

18alpha-glycyrrhetinic acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 18alpha-glycyrrhetinic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What functions are associated with 18alpha-glycyrrhetinic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 18alpha-glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 18alpha-glycyrrhetinic acid

Download all related citations
Per page 10 20 50 100 | Total 209
Authors Title Published Journal PubMed Link
Zhu Y et al. Connexin 43 Mediates White Adipose Tissue Beiging by Facilitating the Propagation of Sympathetic Neuronal Signals. 2016 Cell Metab. pmid:27626200
Kim YJ et al. Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells. 2014 Cell. Mol. Life Sci. pmid:24623558
Tabuchi M et al. The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. 2012 Cell. Mol. Neurobiol. pmid:22488528
Sato T et al. Effect of gap junction blocker beta-glycyrrhetinic acid on taste disk cells in frog. 2009 Cell. Mol. Neurobiol. pmid:19145483
Guillotin B et al. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. 2004 Cell. Physiol. Biochem. pmid:15319536
Li XD et al. Panax notoginseng saponins potentiate osteogenesis of bone marrow stromal cells by modulating gap junction intercellular communication activities. 2010 Cell. Physiol. Biochem. pmid:21220939
Yamanouchi K et al. 18alpha-glycyrrhetinic acid induces phenotypic changes of skeletal muscle cells to enter adipogenesis. 2007 Cell. Physiol. Biochem. pmid:17982260
Sun W et al. Design, synthesis, and sustained-release property of 1,3-cyclic propanyl phosphate ester of 18β-glycyrrhetinic acid. 2011 Chem Biol Drug Des pmid:21244638
Chadjichristos CE et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. 2008 Circ. Res. pmid:18239136
He B et al. Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions. 2009 Clin. Cancer Res. pmid:19723651
Princen F et al. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect. 1999 Clin. Cancer Res. pmid:10589781
Piao H et al. Effects of connexin-mimetic peptides on perfusion pressure in response to phenylephrine in isolated, perfused rat kidneys. 2011 Clin. Exp. Nephrol. pmid:21153751
Nejime N et al. Possible participation of chloride ion channels in ATP release from cancer cells in suspension. 2009 Clin. Exp. Pharmacol. Physiol. pmid:18986334
Goto K et al. Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries. 2002 Clin. Exp. Pharmacol. Physiol. pmid:12060103
Yadav DK et al. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7. 2014 Curr. Med. Chem. pmid:24180274
Bertuzzi F et al. Mechanisms of coordination of Ca2+ signals in pancreatic islet cells. 1999 Diabetes pmid:10512361
Yu J et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. 2016 Endocrinology pmid:27035651
Verma V et al. Perturbing plasma membrane hemichannels attenuates calcium signalling in cardiac cells and HeLa cells expressing connexins. 2009 Eur. J. Cell Biol. pmid:18951659
Perez Velazquez JL et al. Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage. 2006 Eur. J. Neurosci. pmid:16420410
Matsumoto T et al. The anti-ulcer agent, irsogladine, increases insulin secretion by MIN6 cells. 2012 Eur. J. Pharmacol. pmid:22542662